Smart Matrix Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $444K
Latest Deal Amount
  • Investors
  • 2

Smart Matrix General Information

Description

Developer of a wound care product designed to heal full thickness wounds without a skin graft. The company's platform offers a product aimed at treating inner skin injuries that avoids a second operation and the need to regularly drain the wound when the risk of infection is high, enabling healthcare professionals to heal acute wounds easily in a short simple procedure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Primary Office
  • 3rd Floor
  • 207 Regent Street
  • London W1B 3HH
  • England, United Kingdom
+44 01923 000000

Smart Matrix Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Smart Matrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 27-Mar-2020 $444K 000.00 Completed Generating Revenue
6. Later Stage VC 14-Jan-2019 00.000 0000 000.00 Completed Generating Revenue
5. Later Stage VC 30-Mar-2018 00.000 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 06-Oct-2016 00.000 00.000 00.000 Completed Generating Revenue
3. Early Stage VC 27-Mar-2014 00.00 Completed Generating Revenue
2. Angel (individual) 23-Aug-2013 $4.98M $5.3M 00.000 Completed Generating Revenue
1. Angel (individual) 09-Dec-2011 $314K $314K 00000 Completed Generating Revenue
To view Smart Matrix’s complete valuation and funding history, request access »

Smart Matrix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 00000.00 00000.00 00 00000.00 0.000
Ordinary A 000 00.000000 00000.00 00000.00 00 00000.00 0.000
Ordinary A 0,000 00.000000 00000.00 00000.00 00 00000.00 0.000
Ordinary A 516 $0.012705 $658.15 $658.15 1x $658.15 2.73%
Ordinary A 9,781 $0.012705 $604.98 $604.98 1x $604.98 51.66%
To view Smart Matrix’s complete cap table history, request access »

Smart Matrix Executive Team (7)

Name Title Board Seat Contact Info
Lilian Hook Ph.D Chief Scientific Officer & Executive Director
Maria Ezeli Controller
Andy Hill Chief Executive Officer
Natalie Hayes Chief Medical Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Smart Matrix Board Members (9)

Name Representing Role Since
Francis Gugen Self Executive Chairman 000 0000
Jeremy Cook Self Board Member 000 0000
William Allan Self Board Member 000 0000
You’re viewing 3 of 9 board members. Get the full list »

Smart Matrix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Smart Matrix Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Downing Ventures Venture Capital Minority 000 0000 000000 0
Francis Gugen Angel (individual) Minority 000 0000 000000 0
To view Smart Matrix’s complete investors history, request access »